机器学习预测痴呆症转化为轻度认知障碍:一项为期两到六年的随访研究
Valgeir Thorvaldsson1,2, Johan Svensson3,4, Emir Basic5
1Department of Psychology, https://ror.org/01tm6cn81University of Gothenburg, Gothenburg, Sweden.
Journal of the International Neuropsychological Society : JINS
|January 13, 2026
概括
机器学习模型使用临床和认知数据准确地预测轻度认知障碍 (MCI) 患者的痴呆转化. 这些模型为早期干预和临床试验设计提供了有价值的工具,用于预测痴呆风险.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 生物统计学 生物统计学
背景情况:
- 轻度认知障碍 (MCI) 是正常衰老和痴呆之间的过渡阶段.
- 准确预测痴呆症转化为MCI对于及时干预和临床试验分层至关重要.
- 目前的预测方法需要改进,以提高准确性和临床效用.
研究的目的:
- 评估各种机器学习 (ML) 分类算法对MCI患者痴呆转换的预测性能.
- 评估临床和神经心理学数据的有用性,包括随时间的变化,用于预测痴呆风险.
- 确定最有效的ML模型来预测MCI患者的痴呆症进展.
主要方法:
- 利用了哥德堡MCI研究的数据 (347名患者,84人转化为痴呆症).
- 将11个ML算法应用于54个临床预测因子,随后包括认知变化的三角分数.
- 使用精度,kappa,AUC-ROC,灵敏度和特异性评估模型性能.
主要成果:
- 性能最好的模型 (LASSO,山脊,弹性网,随机森林,SVM) 实现了高精度 (≥0.87) 和AUC-ROC (≥0.90) 没有德尔塔分数.
- 包括三角分数提高了性能,和弹性网的精度达到0.90,AUC-ROC为0.94.
- 弹性净模型显示了强大的预测值 (PPV=0.85,NPV=0.92),提高了灵敏度和特异性.
结论:
- 整合临床数据和认知变化的机器学习模型有效预测痴呆症转化为MCI.
- 这些模型显示了改善记忆诊所临床决策和患者管理的巨大潜力.
- 这些发现支持使用先进的ML技术来早期识别患有痴呆症高风险的人.
相关概念视频
Dementia
511
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
511
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806


